|
2025
|
G/S
|
Business administration services, namely, business administration of a program to provide informa... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auditory and neurological diseases and disorders... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment and/or prevention of diseases, namel... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuro... |
|
|
G/S
|
Syringes for medical purposes and for injections; Injection device for pharmaceuticals; Injection... |
|
|
G/S
|
Combination drug delivery devices sold full containing pharmaceutical preparations for the treatm... |
|
|
Invention
|
Stabilized formulations containing anti-cd20 x anti-cd3 bispecific antibodies.
The present inven... |
|
|
Invention
|
Compositions and methods for treating cancer.
Disclosed are compositions and methods for targete... |
|
|
Invention
|
Maytansinoid derivatives, conjugates thereof, and methods of use.
Provided herein are maytansino... |
|
|
Invention
|
Universal modular properties test fixture.
A modular test fixture is configured to quickly suppo... |
|
|
G/S
|
Pharmaceutical research services, namely, nucleic acid molecule development and nucleic acid mole... |
|
|
Invention
|
Compositions and methods for internalizing enzymes.
Compositions and methods for treating lysoso... |
|
|
Invention
|
Cblb endonuclease variants, compositions, and methods of use.
The present disclosure provides im... |
|
|
Invention
|
Systems and methods for chromatography use and regeneration.
Aspects of the present disclosure r... |
|
|
Invention
|
Methods and compositions for therapeutic protein delivery.
Compositions and methods for deliveri... |
|
|
Invention
|
Bispecific anti-cd28 x anti-cd22 antibodies and uses thereof.
The present invention provides bis... |
|
|
Invention
|
N-terminal scfv multispecific binding molecules.
Multispecific binding molecules (MBMs) comprisi... |
|
|
Invention
|
Methods of treating decreased bone mineral density with cluster of differentiation 109 (cd109) in... |
|
|
Invention
|
Sustained release formulations using non-aqueous membrane emulsification.
Non-aqueous membrane e... |
|
|
Invention
|
Lc-ms methods for antibody isotyping and quantification.
The present invention provides methods ... |
|
|
Invention
|
Vegf-trap protein variants and analysis thereof.
Embodiments of the present disclosure are direc... |
|
|
Invention
|
P75 neurotrophin receptor (p75ntr)-binding proteins and p75ntr-mediated delivery to the nervous s... |
|
|
Invention
|
Viral particles retargeted to nervous system tissues. Provided herein are compositions and method... |
|
|
Invention
|
Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden.
Met... |
|
2024
|
Invention
|
Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (gpam) inhibit... |
|
|
Invention
|
Methods of characterizing and purifying vegf receptor fusion protein.
Anti-VEGF proteins includi... |
|
|
Invention
|
Methods of characterizing and purifying vegf receptor fusion protein. Anti-VEGF proteins includin... |
|
|
Invention
|
Anti-vegf protein compositions and methods for producing the same.
The present disclosure pertai... |
|
|
Invention
|
Comprehensive analytical characterization of mrna under one or more stress conditions.
The prese... |
|
|
Invention
|
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr a... |
|
|
Invention
|
Foxp3 peptides and uses thereof. The present disclosure relates to methods and compositions that ... |
|
|
Invention
|
Compositions and methods comprising small nuclear rna (snrna) targeting sod1. SnRNA systems targe... |
|
|
Invention
|
Systems and methods for mentor-mentee matching. Systems and methods for enabling pairing between ... |
|
|
Invention
|
Methods of treating endometrial cancer with bispecific anti-muc16 x anti-cd3 antibodies alone or ... |
|
|
Invention
|
Compositions and methods for internalizing enzymes.
Compositions and methods for treating enzyme... |
|
|
Invention
|
Gaa knockout non-human animals. GaaGaaGaa locus, and exhibiting ocular phenotypes that correlate ... |
|
|
Invention
|
Il18 receptor agonists and methods of use thereof. The present disclosure relates to IL18 recepto... |
|
|
Invention
|
Non-human animals having a humanized complement factor b gene. Disclosed herein are rodents (such... |
|
|
Invention
|
Il18 receptor agonists and methods of use thereof.
The present disclosure relates to IL18 recept... |
|
|
Invention
|
Methods of treating cancer by administering a combination therapy including a neoadjuvant pd-1 in... |
|
|
Invention
|
Methods of treating recurrent ovarian cancer and endometrial cancer with bispecific anti-muc16 x ... |
|
|
Invention
|
Analogs of quinoxaline/quinoline cytotoxins, linker- payloads, protein-drug conjugates, and uses ... |
|
|
Invention
|
Methods of treating skin cancer with histidine ammonia-lyase (hal) agonists.
The present disclos... |
|
|
Invention
|
Covalently surface modified adeno-associated virus production by in vitro conjugation, and purifi... |
|
|
Invention
|
Capacitance probe and cell culture failure modes.
The present invention generally pertains to me... |
|
|
Invention
|
High affinity antibodies to human il-6 receptor.
A human antibody or an antigen-binding fragment... |
|
|
Invention
|
High affinity human antibodies to human il-4 receptor.
The present invention provides nucleic ac... |
|
|
Invention
|
Peptide acids as a glp1r agonist and antibody-drug conjugates thereof.
Described herein are prot... |
|
|
Invention
|
Stable antibody formulation.
The present invention provides stable pharmaceutical formulations c... |
|
|
Invention
|
Methods of treating liver diseases with phosphodiesterase 3b (pde3b) inhibitors.
The present dis... |
|
|
Invention
|
Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies.
The present i... |
|
2023
|
Invention
|
Systems and methods for determining vitreous haze.
An example embodiment of the present disclosu... |
|
|
Invention
|
Microtubule associated protein tau (mapt) irna agent compositions and methods of use thereof.
Th... |
|
|
Invention
|
Compositions and methods for defining optimal treatment timeframes in lysosomal disease.
Non-hum... |
|
2022
|
Invention
|
Biochemical assays for therapeutic proteins.
The present invention generally pertains to methods... |
|
2017
|
Invention
|
Assay for determining potential to self-association of a protein using concentration-dependent se... |
